CLDX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Celldex Therapeutics Inc

Watchlist Manager

Watchlist

Price: 39.98 USD -1.19% Market Closed

Market Cap: $3.1B

	Celldex Therapeutics Inc NASDAQ:CLDX	US
B	Build-A-Bear Workshop Inc F:FPW	US
A	Alpha Services and Holdings SA ATHEX:ALPHA	GR
	SDIC Power Holdings Co Ltd SSE:600886	CN
	Koninklijke BAM Groep NV LSE:0LNQ	NL
C	Compass Inc NYSE:COMP	US
M	Moshi Moshi Retail Corporation PCL SET:MOSHI	TH
E	Eagle Materials Inc XBER:E5M	US

Profitability Summary

Celldex Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-206.220%

Negative 3Y Average Operating Margin

-24.324%

Declining Operating Margin

-3.720% > -206.220%

Negative Net Margin

-190.221%

Negative 3Y Average Net Margin

-22.255%

Declining Net Margin

-3.470% > -190.221%

Negative Free Cash Flow Margin

-153.231%

Negative 3Y Average Free Cash Flow Margin

-18.074%

Declining Free Cash Flow Margin

-3.506% > -153.231%

Negative ROE

-44%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-423%

Declining ROIC

-267% > -592%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.